| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |